A detailed history of Carnegie Lake Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Carnegie Lake Advisors LLC holds 25,646 shares of VTRS stock, worth $266,461. This represents 0.1% of its overall portfolio holdings.

Number of Shares
25,646
Previous 26,596 3.57%
Holding current value
$266,461
Previous $238,000 6.3%
% of portfolio
0.1%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$8.74 - $10.69 $8,303 - $10,155
-950 Reduced 3.57%
25,646 $253,000
Q2 2025

Aug 06, 2025

SELL
$7.26 - $9.12 $21,780 - $27,359
-3,000 Reduced 10.14%
26,596 $238,000
Q1 2025

May 05, 2025

SELL
$8.68 - $12.42 $30,380 - $43,470
-3,500 Reduced 10.58%
29,596 $258,000
Q4 2024

Jan 29, 2025

SELL
$11.32 - $13.37 $25,470 - $30,082
-2,250 Reduced 6.37%
33,096 $412,000
Q3 2024

Nov 04, 2024

BUY
$10.32 - $12.13 $364,770 - $428,746
35,346 New
35,346 $410,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Carnegie Lake Advisors LLC Portfolio

Follow Carnegie Lake Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Lake Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Lake Advisors LLC with notifications on news.